CN109232386A - A kind of method of asymmetric syntheses (S)-preclamol - Google Patents

A kind of method of asymmetric syntheses (S)-preclamol Download PDF

Info

Publication number
CN109232386A
CN109232386A CN201811342490.8A CN201811342490A CN109232386A CN 109232386 A CN109232386 A CN 109232386A CN 201811342490 A CN201811342490 A CN 201811342490A CN 109232386 A CN109232386 A CN 109232386A
Authority
CN
China
Prior art keywords
preclamol
methoxyphenyl
coupling reaction
glutaric acid
acid diester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811342490.8A
Other languages
Chinese (zh)
Inventor
王敏
周云
钟江春
韩冷
李扬帆
任泓远
边庆花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN201811342490.8A priority Critical patent/CN109232386A/en
Publication of CN109232386A publication Critical patent/CN109232386A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of asymmetric syntheses (S)-preclamol new methods.This method is using racemic alpha-halogenate glutaric acid diester as starting material, under double oxazoline chiral ligands and metallic cobalt catalysis, asymmetry Negishi cross-coupling reaction occurs with m-methoxyphenyl zinc bromide, the glutaric acid diester of m-methoxyphenyl substitution is obtained, then through LiAlH4Reduction generates (S) -2- (3- methoxyphenyl) pentanediol, and (S)-preclamol most is made through amination cyclization and demethylation afterwards.The present invention utilizes the chiral centre of asymmetric Negishi cross-coupling reaction direct construction (S)-preclamol for the first time, and synthetic route is brief, and reaction condition is mild, gross production rate 51%.

Description

A kind of method of asymmetric syntheses (S)-preclamol
Technical field
The present invention relates to pharmaceutical technology fields, and in particular to a kind of side of new asymmetry catalysis synthesis (S)-preclamol Method.
Background technique
(S)-preclamol (Preclamol, formula 1) is a kind of drug for treating the mental diseases such as parkinsonism, is more Antagonist (Hacksell, the U. of bar amine receptor;Arvidsson,L.E.;Svensson,U.;Nilsson,J.L.G.; Sanchez,D.;Wikstroem,H.;Lindberg,P.;Hjorth,S.;Carlsson,A.J.Med.Chem.1981,24, 1475.Metman,L.V.;Sethy,V.H.;Roberts,J.R.;Bravi,D.;Hoff,J.I.;Mouradian,M.M.; Chase,T.N.Mov Disord1994,9,577.).Since (S)-preclamol has important physiological activity, many scholars Study its synthetic method.(S) there is an asymmetric carbon atom in-preclamol structure, synthesis key is to construct the chiral centre.Mesh Before, the method for obtaining (S)-preclamol mainly has racemic modification Split Method, chiral induction method and asymmetry catalysis method.
(1) racemic modification Split Method mainly includes dynamics of 2,2'- (1,1'- dinaphthyl) phosphonic acids to racemic preclamol Split (Arnold, W.;Daly,J.J.;Imhof,R.;Kyburz, E.Tetrahedron Lett.1983,24,343.), with And two paratolunitrile tartrate to the Kinetic Resolution of racemic preclamol precursor (O- methyl preclamol) (Thorberg,S.O.;Gawell,L.;Csoeregh,I.;Nilsson, J.L.G.Tetrahedron 1985,41,129.), (S)-preclamol can be obtained through demethylation in the latter.
(2) chiral induction method is mainly using the chirality sweet amine alcohol of benzene as the oxazolidine annulation of chiral shift reagent, Through multistep reactions such as reduction, demethylations, (S)-preclamol (Wong, Y.-S. is made;Marazano,C.;Gnecco,D.; Genisson,Y.;Chiaroni,A.;Das,B.C.J.Org.Chem.1997,62,729.).
(3) asymmetry catalysis method is mainly including the use of asymmetric hydrogenation (Yang, the X.-H. of the lactone of iridium catalysis;Yue, H.-T.;Yu,N.;Li,Y.-P.;Xie,J.-H.;Zhou, Q.-L.Chem.Sci.2017,8,1811.), the allyl of iridium catalysis Base is alkylated (Hamilton, J.Y.;Sarlah,D.;Carreira,E.M.Angew.Chem.,Int.Ed.2015,54, And copper/palladium chtalyst asymmetric allylboration (Jia, T. 7644.);Cao,P.;Wang,B.;Lou,Y.;Yin,X.; Wang,M.;Liao, J.J.Am.Chem.Soc.2015,137,13760.) asymmetric catalysis such as ,-the third carat of building (S) Asymmetric carbon atom not.
Although having some study on the synthesis about (S)-preclamol, the chiral examination for needing stoichiometry is still remained Therefore agent, severe reaction conditions, the problems such as reaction step is cumbersome study environment amenable, simple and direct efficient asymmetry The method for synthesizing (S)-preclamol has important theoretical value and realistic meaning.
Summary of the invention
The present invention is intended to provide a kind of new asymmetric syntheses (S)-preclamol method.The present invention is with racemic α- Halogenated glutaric acid diester (1) is used as starting material, under double oxazoline chiral ligands and metallic cobalt catalysis, with m-methoxyphenyl Asymmetry Negishi cross-coupling reaction occurs for zinc bromide, obtains the glutaric acid diester (2) of m-methoxyphenyl substitution, then Through LiAlH4Reduction generates (S) -2- (3- methoxyphenyl) pentanediol (3), and (S)-most is made through amination cyclization and demethylation afterwards Preclamol.The hand for asymmetric Negishi cross-coupling reaction direct construction (S)-preclamol that this method is catalyzed using cobalt Property center, synthetic route is simple and direct, and reaction condition is mild, gross production rate 51%.Asymmetric syntheses (S)-preclamol of the present invention Synthetic route is referring to formula 2.
The method that the present invention synthesizes (S)-preclamol includes the following steps.
(1) synthesis for the glutaric acid diester (2) that m-methoxyphenyl replaces
Under argon gas protection, anhydrous THF and a small amount of 3- methoxybromobenzene are sequentially added in magnesium chips.Careful heating causes anti- It answers, the THF solution of the bromo- 3- methoxybenzene of 1- is added dropwise, (3- methoxyphenyl) magnesium bromide is made in back flow reaction.
Under argon gas protection, in ZnBr2In sequentially add anhydrous THF with from preparation (3- methoxyphenyl) magnesium bromide, room temperature Under be stirred to react, be made (3- methoxyphenyl) zinc bromide.
Under argon gas protection, the THF solution of anhydrous THF and double oxazoline chiral ligands are added in anhydrous cobaltous iodide (II), It is stirred to react at room temperature, alpha-halogenate glutaric acid diester is added.- 25 DEG C are cooled to, the outstanding of (3- methoxyphenyl) zinc bromide is added dropwise Supernatant liquid continues to be stirred to react.Quenching reaction, liquid separation extract, dry, depressurize precipitation.It is purified finally by silica gel column chromatography, Obtain the glutaric acid diester (2) of m-methoxyphenyl substitution.
(2) synthesis of (S) -2- (3- methoxyphenyl) pentanediol (3)
In LiAlH4It is middle that anhydrous THF is added, -78 DEG C are cooled to, the glutaric acid diester (2) that m-methoxyphenyl replaces is added THF solution, be warming up to room temperature and be stirred overnight.Quenching reaction, liquid separation extract, dry, depressurize precipitation.Finally by silica gel It is column chromatography eluting, obtain (S) -2- (3- methoxyphenyl) pentanediol (3).
(3) synthesis of (S)-preclamol
At 0 DEG C, in the CH of (S) -2- (3- methoxyphenyl) pentanediol (3)2Cl2In solution, Et is sequentially added3N with MsCl is warming up to room temperature, continues to be stirred to react.Quenching reaction, liquid separation extract, and wash, dry, depressurize precipitation, obtain thick diformazan Sulphonic acid ester.
At room temperature, by n-PrNH2It is added in thick bis-mesylate, is stirred to react.Reaction mixture is diluted, is washed, Liquid separation extracts, dry, depressurizes precipitation.It is purified finally by silica gel column chromatography, obtains O- methyl preclamol.
At room temperature, under protection of argon gas, HBr is added in O- methyl preclamol, is heated to 120 DEG C, is stirred to react. It is cooled to 0 DEG C, alkalizes, extraction, liquid separation is dry, depressurizes precipitation, purifies finally by silica gel column chromatography, obtains-the third gram of (S) Rameau.
Specific embodiment
Embodiment 1
The synthesis for the glutaric acid diester (2) that m-methoxyphenyl replaces
Magnesium chips (1.46g, 60mmol) is placed in two mouthfuls of Schlenk flasks of the 250mL equipped with dropping funel, it is true at 80 DEG C Sky is 1 hour dry.Be cooled to room temperature under argon gas protection, sequentially add anhydrous THF (50mL) and 3- methoxybromobenzene (1.87g, 10mmol).Careful heating initiation reaction, the THF (10mL) that the bromo- 3- methoxybenzene (7.48g, 40mmol) of 1- is added dropwise are molten Liquid.Reaction mixture is stirred and is flowed back 2 hours, (3- methoxyphenyl) magnesium bromide is made.
By ZnBr2(10.12g, 45mmol) is placed in another 250mL Schlenk flask, is dried in vacuo at 100 DEG C 1.5 hour.It is cooled to room temperature under argon gas protection, anhydrous THF (68.8mL) is added, continue stirring 10 minutes.Self-control is added dropwise (3- methoxyphenyl) magnesium bromide (30mmol, 0.586M THF solution, 51.2mL).Reaction mixture is continued at room temperature It is stirred to react 2 hours, (3- methoxyphenyl) zinc bromide is made.
Anhydrous cobaltous iodide (II) (160mg, 0.50mmol) is placed in 100mL Schlenk flask, vacuum is dry at 80 DEG C Dry 2 hours.Be cooled to room temperature under argon gas protection, be added anhydrous THF (10mL) and pair oxazoline chiral ligand L1 (330mg, THF (5mL) solution 0.60mmol).Mixture is stirred at room temperature 2 hours, 2- bromine glutaric acid two is added by syringe Benzyl ester (1) (1.97g, 5.0mmol).Gained mixture is cooled to -25 DEG C, (3- methoxyphenyl) zinc bromide is added dropwise The suspension of (25mmol).It is stirred to react at -25 DEG C 24 hours, with saturation NH4Cl solution (10mL) quenching reaction.Liquid separation, Water phase Et2O (3 × 50mL) extraction, merges organic phase.Organic phase anhydrous Na2SO4It is dry, depressurize precipitation.Finally by silicon Rubber column gel column chromatography (petroleum ether/methylene chloride 1:2) purifying, obtains colorless oil (S) -2- (3- methoxyphenyl) glutaric acid two Benzyl ester (2) (1.94g, yield 93%, optical purity 87%).[α]D 23=+24.6 (c 1.3, CHCl3).1H NMR(300MHz, CDCl3) δ 7.34-7.18 (m, 11H), 6.84-6.79 (m, 3H), 5.15-5.04 (m, 4H), 3.74 (s, 3H), 3.64 (t, J= 7.4Hz, 1H), 2.45-2.33 (m, 1H), 2.31 (t, J=7.4Hz, 2H), 2.20-2.09 (m, 1H)13C NMR(75MHz, CDCl3)δ173.0,172.6,159.8,139.5,135.87,135.80,129.7,128.5,128.4,128.2,128.1, 127.9,120.4,113.5,113.1,66.5,66.3,55.1,50.5,31.8,28.2.HRMS(ESI):calcd forC26H27O5[M+H]+419.1853,found 419.1840.
The structure of double oxazoline chiral ligand L1 is referring to formula 3.
Embodiment 2
(S) synthesis of -2- (3- methoxyphenyl) pentanediol (3)
By LiAlH4(0.25g, 6.6mmol) is placed in 50mL Schlenk pipe, and anhydrous THF (5mL) is added.By mixed liquor Be cooled to -78 DEG C, then by syringe be added (S) -2- (3- methoxyphenyl) glutaric acid dibenzyl ester (2) (0.46g, THF (3mL) solution 1.1mmol).Reaction mixture is to slowly warm up to room temperature and is stirred to react overnight.Potassium tartrate is added Solution (20mL) quenching reaction continues stirring 6 hours.Liquid separation, water phase Et2O (3 × 30mL) extraction, merges organic phase.It is organic Mutually use anhydrous Na2SO4It is dry, depressurize precipitation.It is purified finally by silica gel column chromatography (methylene chloride/methanol 20:1), obtains nothing Color grease (S) -2- (3- methoxyphenyl) pentanediol (3) (0.21g, yield 90%, optical purity 87%).[α]D 23=+ 9.3(c 1.8,CHCl3).1H NMR(300MHz,CDCl3) δ 7.23 (t, J=7.9Hz, 1H), 6.80-6.75 (m, 3H), 3.78 (s, 3H), 3.70 (d, J=6.8Hz, 2H), 3.55 (t, J=6.3Hz, 2H), 2.78-2.69 (m, 1H), 2.09 (br s, 2H), 1.86–1.76(m,1H),1.65–1.52(m,1H),1.49–1.40(m,2H).13C NMR(75MHz,CDCl3)δ159.8, 143.9,129.6,120.3,114.0,111.6,67.3,62.5,55.1,48.3,30.3,28.1.HRMS(ESI):calcd forC12H19O3[M+H]+211.1329,found 211.1331.
Embodiment 3
(S) synthesis of-preclamol
At 0 DEG C, (S) -2- (3- methoxyphenyl) pentanediol (3) (0.21g, 0.99mmol) is dissolved in CH2Cl2 (8mL), is added with stirring Et3MsCl (0.21mL, 2.65mmol) is then added dropwise in N (0.69mL, 4.96mmol).It will be anti- It answers mixed liquor to be warming up to room temperature, continues to be stirred to react 12 hours.With saturation NaHCO3Solution (5mL) quenching reaction, liquid separation.Water phase Use CH2Cl2(3 × 20mL) extraction, merges organic phase.Organic phase is washed with saturated sodium chloride solution (20mL), through anhydrous Na2SO4 Precipitation is depressurized after drying, obtains thick bis-mesylate.
At room temperature by n-PrNH2(2.4mL, 30.0mmol) is added in thick bis-mesylate, is stirred to react 24 hours. By reaction mixture CH2Cl2(10mL) dilution, then with saturation Na2CO3Solution (20mL) washing.Liquid separation, water phase CH2Cl2 (3 × 10mL) extraction, merges organic phase.Organic phase is washed with saturated sodium-chloride water solution (30mL), anhydrous Na2SO4It is dry, subtract Pressure-off is molten.It is purified finally by silica gel column chromatography (methylene chloride/methanol 20:1), obtains white waxy solid O- methyl-prop gram Rameau.
At room temperature, under protection of argon gas, by 48%HBr (3mL) be added to O- methyl preclamol (0.16g, In 0.68mmol), 120 DEG C are heated to, is stirred to react 2 hours.Reaction mixture is cooled to 0 DEG C, with saturation Na2CO3Solution (30mL) alkalization.Gained mixture CH2Cl2(4 × 10mL) extraction, liquid separation merge organic phase.Organic phase anhydrous sodium sulfate Precipitation is depressurized after drying, is purified finally by silica gel column chromatography (n-hexane/acetone 1:1), is obtained yellow oil (S)-the third Carat is not (0.13g, 3 step yields are 61%, optical purity 87%).[α]D 23=-16.3 (c 2.5, CHCl3).1H NMR (300MHz,CDCl3) δ 7.72 (br s, 1H), 7.18 (t, J=7.8Hz, 1H), 6.78-6.70 (m, 3H), 3.23 (d, J= 11.4Hz, 1H), 3.08 (d, J=11.4Hz, 1H), 2.99-2.89 (m, 1H), 2.45-2.28 (m, 2H), 2.06-1.95 (m, 3H), 1.83-1.75 (m, 2H), 1.63-1.48 (m, 3H), 0.87 (t, J=7.4Hz, 3H)13C NMR(75MHz,CDCl3)δ 156.9,145.4,129.8,117.4,114.7,114.2,61.4,61.2,54.0,41.9,30.0,25.2,19.2, 12.0.HRMS(ESI):calcdfor C14H22NO[M+H]+220.1696,found 220.1695.

Claims (6)

1. asymmetric syntheses (S)-preclamol method, it is characterised in that: be with racemic alpha-halogenate glutaric acid diester With m-methoxyphenyl zinc bromide asymmetry Negishi occurs for beginning raw material under double oxazoline chiral ligands and metallic cobalt catalysis Cross-coupling reaction obtains the glutaric acid diester of m-methoxyphenyl substitution, then through LiAlH4Reduction generates (S) -2- (3- first Phenyl) pentanediol, (S)-preclamol most is made through amination cyclization and demethylation afterwards.
2. synthetic method according to claim 1, it is characterised in that double used in asymmetric Negishi cross-coupling reaction The substituent R of oxazoline chiral ligand ' it is ethyl, isopropyl, sec-butyl, tert-butyl, phenyl and benzyl, preferred substituents R' is Double oxazoline chiral ligands of benzyl.
3. synthetic method according to claim 1, it is characterised in that used in asymmetry catalysis Negishi cross-coupling reaction Cobalt salt be CoCl2、CoBr2、CoI2、Co(OAc)2、Co(acac)2、Co(PPh3)Cl2、Co(dppe)Cl2With Co (acac)3, It is preferred that CoI2
4. synthetic method according to claim 1, it is characterised in that institute in asymmetry catalysis Negishi cross-coupling reaction Reaction dissolvent is ether, toluene, tetrahydrofuran, methyltetrahydrofuran and methylene chloride, preferably tetrahydrofuran.
5. synthetic method according to claim 1, it is characterised in that in asymmetry catalysis Negishia cross-coupling reaction The halogen atom of alpha-halogenate glutaric acid diester used is Cl, Br and I, preferably bromine atom.
6. synthetic method according to claim 1, it is characterised in that institute in asymmetry catalysis Negishi cross-coupling reaction Substituent R is methyl, ethyl, sec-butyl, cyclohexyl methyl, phenyl, p-methylphenyl and benzyl in alpha-halogenate glutaric acid diester Base, preferably benzyl.
CN201811342490.8A 2018-11-12 2018-11-12 A kind of method of asymmetric syntheses (S)-preclamol Pending CN109232386A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811342490.8A CN109232386A (en) 2018-11-12 2018-11-12 A kind of method of asymmetric syntheses (S)-preclamol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811342490.8A CN109232386A (en) 2018-11-12 2018-11-12 A kind of method of asymmetric syntheses (S)-preclamol

Publications (1)

Publication Number Publication Date
CN109232386A true CN109232386A (en) 2019-01-18

Family

ID=65078246

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811342490.8A Pending CN109232386A (en) 2018-11-12 2018-11-12 A kind of method of asymmetric syntheses (S)-preclamol

Country Status (1)

Country Link
CN (1) CN109232386A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483289A (en) * 2019-07-31 2019-11-22 中国农业大学 A kind of method of asymmetric syntheses chirality olefin(e) acid ester
CN111454150A (en) * 2019-12-25 2020-07-28 南京工业大学 Synthesis method of (S) -2-aryl propionate compound
CN113929577A (en) * 2021-11-05 2022-01-14 安徽美致诚药业有限公司 Synthetic method of 2- (4-methylphenyl) -propionate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103755566A (en) * 2014-01-17 2014-04-30 中国农业大学 Novel method for asymmetric catalytic synthesis of (S)-2-aryl propionate
CN103755554A (en) * 2014-01-17 2014-04-30 中国农业大学 Novel method for asymmetric catalytic synthesis of (S)-fenoprofen
CN103787855A (en) * 2014-01-17 2014-05-14 中国农业大学 Novel method for asymmetrically catalyzing (S)-arturmerone

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103755566A (en) * 2014-01-17 2014-04-30 中国农业大学 Novel method for asymmetric catalytic synthesis of (S)-2-aryl propionate
CN103755554A (en) * 2014-01-17 2014-04-30 中国农业大学 Novel method for asymmetric catalytic synthesis of (S)-fenoprofen
CN103787855A (en) * 2014-01-17 2014-05-14 中国农业大学 Novel method for asymmetrically catalyzing (S)-arturmerone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FEIPENG LIU等: ""Cobalt-Catalyzed Enantioselective Negishi Cross-Coupling of Racemic a-Bromo Esters with Arylzincs"", 《CHEM. EUR. J.》 *
XIAO-HUI YANG等: ""Iridium-catalyzed asymmetric hydrogenation of racemic α-substituted lactones to chiral diols"", 《CHEM. SCI.》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483289A (en) * 2019-07-31 2019-11-22 中国农业大学 A kind of method of asymmetric syntheses chirality olefin(e) acid ester
CN110483289B (en) * 2019-07-31 2021-02-09 中国农业大学 Method for asymmetrically synthesizing chiral olefine acid ester
CN111454150A (en) * 2019-12-25 2020-07-28 南京工业大学 Synthesis method of (S) -2-aryl propionate compound
CN111454150B (en) * 2019-12-25 2023-03-28 南京工业大学 Synthesis method of (S) -2-aryl propionate compound
CN113929577A (en) * 2021-11-05 2022-01-14 安徽美致诚药业有限公司 Synthetic method of 2- (4-methylphenyl) -propionate
CN113929577B (en) * 2021-11-05 2023-09-29 安徽美致诚药业有限公司 Synthesis method of 2- (4-methylphenyl) -propionate

Similar Documents

Publication Publication Date Title
Senda et al. Rhodium-Catalyzed Asymmetric 1, 4-Addition of Organoboron Reagents to 5, 6-Dihydro-2 (1 H)-pyridinones. Asymmetric Synthesis of 4-Aryl-2-piperidinones
US8552212B2 (en) Chiral phosphorus ligands
Zhang et al. Novel chiral P, N-ferrocene ligands in palladium-catalyzed asymmetric allylic alkylations
CN109748841B (en) Method for catalyzing asymmetric synthesis of chiral beta-aminoketone derivative
CN109232386A (en) A kind of method of asymmetric syntheses (S)-preclamol
CN102040625A (en) Chiral spiro pyridylamidophosphine ligand compounds and synthesis method and application thereof
JP5729634B2 (en) Bidentate chiral ligands used in catalytic asymmetric addition reactions
CN113548999A (en) Racemic and chiral 3- (2, 3-butadienyl) oxindole compound, preparation method and application
Lu et al. Dipeptide-derived multifunctional phosphonium salt as a catalyst to synthesize highly functionalized chiral cyclopentanes
CN110437129B (en) Simple method for synthesizing 3-ether-based isoindolinone compound
CN110437128B (en) Synthetic method of 3-thioether-based isoindolinone compound
CN110494439B (en) Chiral biphenyl diphosphine ligand and preparation method thereof
Faitg et al. Asymmetric Isomerisation of a Cyclic Diene: a Comparative Study of BINAP and BIPNOR–Rhodium (I) Catalysts
CN110294730B (en) Difluoromethyl sulfuration flavonoid compound and preparation method thereof
CN109293700B (en) Chiral diphosphine ligand, preparation method, intermediate and application thereof
CN111471005B (en) Indole-dihydronaphthalene compound and preparation method and application thereof
CN107445999A (en) Metal complex, preparation method and application and its intermediate
CN110041365B (en) Pyrroline chiral diphosphine ligand and preparation method and application thereof
Wei et al. Novel atropisomeric bisphosphine ligands with a bridge across the 5, 5′-position of the biphenyl for asymmetric catalysis
CN114907404A (en) 5- (2- (disubstituted phosphino) phenyl) -1-alkyl-1H-pyrazolylphosphine ligand and preparation method and application thereof
CN102627571B (en) Preparation and synthesis method for chiral ammonium salt
CN102030690B (en) Di-sulfoxide ligands with axial chirality and synthesis method thereof
CN106831522B (en) Lactam compound and preparation method thereof
CN111517930B (en) Preparation method and intermediate of fused tricyclic derivative
EP2183259B1 (en) Paracyclophane-based ligands, their preparation and use in catalysis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190118